An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact

Trial Profile

An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Torticollis
  • Focus Therapeutic Use
  • Acronyms INTEREST IN CD2
  • Sponsors Ipsen
  • Most Recent Events

    • 28 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Sep 2017.
    • 28 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.
    • 08 Jun 2017 Results (n=966) assessing the impact of regional differences on the drivers for change in TWSTRS total score, presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top